FAYETTEVILLE, GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ -- Continuous glucose monitoring is essential for ...
Add Yahoo as a preferred source to see more of our stories on Google. Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose ...
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System ...
WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...
Zacks Investment Research on MSN
SENS Eversense 365 integrated with twiist gains full availability
Senseonics SENS recently announced the full availability of its long-term, implantable Continuous Glucose Monitoring (CGM) ...
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for ...
Medtronic’s Guardian Connect continuous glucose monitoring system earned FDA approval March 12. Here are four things to know. 1. The Guardian Connect system uses predictive analytics and artificial ...
Best Buy plans to start selling continuous glucose monitors in the next few weeks, in the tech retailer’s first foray into prescription-based medical device sales. The company plans to sell the Dexcom ...
Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
The Food and Drug Administration on Tuesday approved expanded use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System. The system was originally approved to complement — not replace — ...
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results